2.6.1.36	(E)-2-(2-(2-(benzo[d]thiazol-2-yl)-2-cyanovinyl)phenoxy)acetic acid	-	251657	
2.6.1.36	(E)-2-(4-(2-(benzo[d]thiazol-2-yl)-2-cyanovinyl)phenoxy)acetic acid	-	251658	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(1H-indol-3-yl)acrylonitrile	-	251659	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(1H-pyrrol -2-yl)acrylonitrile	-	251660	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(2,4-dihydroxyphenyl)acrylonitrile	-	251661	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(3,4,5-trimethoxyphenyl)acrylonitrile	-	251662	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(3,4-dimethoxyphenyl)acrylonitrile	-	251663	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(4-benzyloxyphenyl)acrylonitrile	-	251664	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(4-fluorophenyl)acrylonitrile	-	251665	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(4-hydroxy-3-methoxyphenyl)acrylonitrile	-	251666	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(4-hydroxyphenyl)acrylonitrile	-	251667	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(5-nitrofuran-2-yl)acrylonitrile	-	251668	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(5-nitrothiophen-2-yl)acrylonitrile	-	251669	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(furan-2-yl)acrylonitrile	-	251670	
2.6.1.36	(E)-2-(benzo[d]thiazol-2-yl)-3-(thiophen-2-yl)acrylonitrile	-	251671	
2.6.1.36	(E)-3-(5-(2-(benzo[d]thiazol-2-yl)-2-cyanovinyl)furan-2-yl)benzoic acid	-	251672	
2.6.1.36	(E)-3-(5-(2-(benzo[d]thiazol-2-yl)-2-cyanovinyl)thiophen-2-yl)benzoic acid	-	251673	
2.6.1.36	(E)-3-(benzo[d][1,3]dioxol-5-yl)-2-(benzo[d]thiazol-2-yl)acrylonitrile	-	251674	
2.6.1.36	(E)-4-(5-(2-(benzo[d]thiazol-2-yl)-2-cyanovinyl)furan-2-yl)benzoic acid	-	251675	
2.6.1.36	(E)-4-(5-(2-(benzo[d]thiazol-2-yl)-2-cyanovinyl)thiophen-2-yl)benzoic acid	-	251676	
2.6.1.36	(E)-4-(5-(2-(benzo[d]thiazol-2-yl)-2-cyanovinyl)thiophen-2-yl)isophthalic acid	-	251677	
2.6.1.36	(E)-5-(5-(2-(benzo[d]thiazol-2-yl)-2-cyanovinyl)furan-2-yl)isophthalic acid	-	251678	
2.6.1.36	2,2'-oxybis[N'-[(E)-(4-fluorophenyl)methylidene]acetohydrazide]	25.6% cytotoxicity at 0.1 mM	209133	
2.6.1.36	2,2'-oxybis[N'-[(E)-[(3-benzyloxy)phenyl]methylidene]acetohydrazide]	26.4% cytotoxicity at 0.1 mM	209134	
2.6.1.36	2-oxopentanedioic acid	binding energy 6.48 kcal per mol	16878	
2.6.1.36	2-phenyl-4-(prop-2-yn-1-yloxy)-2,3-dihydro-1,3-thiazole-5-carboxylic acid	-	209136	
2.6.1.36	2-[methyl[(1-methylpiperidin-2-yl)methyl]amino]-1-phenylethanol	binding energy 7.23 kcal per mol	142857	
2.6.1.36	4-ethoxy-2-phenyl-2,3-dihydro-1,3-thiazole-5-carboxamide	protein is stabilzed in presence of the inhibitor	209137	
2.6.1.36	4-methoxy-2-(pyridin-4-yl)-2,3-dihydro-1,3-thiazole-5-carboxylic acid	at 0.05 mM, 24.87% cytotoxicity in a HEK-293 cell line	209135	
2.6.1.36	5-Aminopentanoate	-	2715	
2.6.1.36	5-hydroxylysine	DL-	15572	
2.6.1.36	acetate	stimulates alanine transamination, inhibits lysine transamination	47	
2.6.1.36	Br-	stimulates alanine transamination, inhibits lysine transamination	332	
2.6.1.36	Cl-	stimulates alanine transamination, inhibits lysine transamination	141	
2.6.1.36	F-	stimulates alanine transamination, inhibits lysine transamination	174	
2.6.1.36	formate	stimulates alanine transamination, inhibits lysine transamination	120	
2.6.1.36	I-	stimulates alanine transamination, inhibits lysine transamination	507	
2.6.1.36	additional information	incubation of the enzyme with L-lysine in the presence of high concentrations of phosphate gives an inactive form of the enzyme (semiapoenzyme), reactivation with pyridoxal 5'-phosphate	2	
2.6.1.36	additional information	identification of inhibitors by high throughput virtual database screening for active derivatives using a benzothiazole lead as template, structure-activity relationship analysis of potentials inhibitors, docking study, overview	2	
2.6.1.36	N-([2-[2-(3,4-dimethoxyphenyl)ethyl]-1,3-dioxo-2,3,5,6,11,11a-hexahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indol-5-yl]methyl)-2-(4-methoxyphenyl)acetamide	binding energy 10.79 kcal per mol	143282	
2.6.1.36	O-(2-aminoethyl)-DL serine	-	94515	
2.6.1.36	Phenylglyoxal	loss of activity with lysine, no effect on activity with L-alanine	301	
2.6.1.36	propionate	inhibits alanine transamination and lysine transamination	312